RECOMMENDATIONS FOR COMFA STUDIES AND 3D QSAR PUBLICATIONS

被引:27
作者
THIBAUT, U
FOLKERS, G
KLEBE, G
KUBINYI, H
MERZ, A
ROGNAN, D
机构
[1] ETH ZURICH,DEPT PHARM,CH-8092 ZURICH,SWITZERLAND
[2] BASF AG,HAUPTLAB,WIRKSTOFFDESIGN,D-67056 LUDWIGSHAFEN,GERMANY
来源
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS | 1994年 / 13卷 / 01期
关键词
D O I
10.1002/qsar.19940130102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 3D QSAR DRUG DESIGN
[2]  
CREMER RD, 1993, 3D QSAR DRUG DESIGN, P443
[3]  
CRUCIANI G, 1993, 3D QSAR DRUG DESIGN, P551
[4]  
Folkers G., 1993, 3D QSAR DRUG DESIGN, P583
[5]  
Kubinyi H., 1993, 3D QSAR DRUG DESIGN
[6]  
KUBINYI H, 1993, 3D QSAR DRUG DESIGN, P717
[7]  
Marshall G.R., 1993, 3D QSAR DRUG DESIGN, P80
[8]  
Pearlman RS, 1993, 3D QSAR DRUG DESIGN, P41
[9]  
THIBAUT U, 1993, 3D QSAR DRUG DESIGN, P661
[10]  
Wold S., 1993, 3D QSAR DRUG DESIGN, P523